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Introduction
The true incidence of malignant degeneration of hepatic
adenoma is not known. A recent review documented only
five confirmed cases of a pre-existing adenoma with malig-
nant transformation to hepatocellular carcinoma [1]. We
report an unusual case of a male patient with no history of
steroid use who developed a well-differentiated hepatocel-
lular cancer arising within a pre-existing adenoma, which
was diagnosed more than 10 years earlier. Despite complete
resection of the malignant component, the tumour recurred
nearly six years after resection with multifocal hepatoma at
the resection margin. This case not only reinforces previous
recommendations supporting routine resection of hepatic
adenoma, but also suggests that complete pathological
removal of the adenoma and continued long-term follow-
up is essential. A review of the recent literature follows the
case summary.
Case report
A 52-year-old man presented with sudden, severe midline
and left upper quadrant abdominal pain that decreased in
intensity over a two-week period. Of note, the patient had
had intermittent, mild mid-abdominal pain in the past and
had been told 11 years previously that he had an haeman-
gioma with the liver. The most recent radiological imaging
of this lesion was a CT scan one year before clinical pres-
entation, which revealed a 5 cm left lateral segment lesion.
He had no history of hepatitis, jaundice, or a previous blood
transfusion.
The severity of this episode prompted an investigation
that included laboratory tests and abdominal imaging.
Bilirubin was normal at 1.2 mg/dL (15.6 micromol/L), while
ALT and alkaline phosphatase were mildly elevated at
59 U/L (normal 0–40) and 113 U/L (normal, 35–110),
respectively. His haematocrit was normal. An ultrasound
scan revealed a 10 3 11 cm heterogeneous mass in the
left lateral segment of the liver. CT scan demonstrated a
123 10 cm mixed cystic and solid mass with a hyperdensity
within the cystic portion, which was interpreted as relatively
acute haemorrhage (Figure 1). The differential diagnosis
based on radiological investigation included haemangioma,
focal nodular hyperplasia, and adenoma with a probable
recent acute haemorrhage. Given the radiological findings
and the patient’s symptoms, resection was recommended.
At the time of operation, there was a large non-
compressible liver mass in segment III, with recent haem-
orrhage within the inferior aspect of this lesion (Figure 2).
The remainder of the liver was grossly normal, and enucle-
ation was performed. Histological examination of the
resected specimen revealed a 5.5 cm well-differentiated
hepatocellular carcinoma arising within a 12 cm hepatic
adenoma (Figure 3a). Reticulin-stained sections (Figure
3b) differentiated the adenoma, in which the basement
membrane was demonstrated, from the hepatocellular car-
cinoma, which has no basement membrane. The carcinoma
was 0.5 cm from the resection margin and was contained
entirely within the adenoma. Adenoma was present at the
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Figure 1. CT scan demonstrating left lateral segment cystic and solid mass (a)
with recent haemorrhage (b).
resection margin. The patient recovered from the proce-
dure without incident.
Serum alpha fetoprotein (AFP) and contrast CT scans
of the abdomen were obtained every six months for follow-
up evaluation. After three negative examinations, the
screening interval was expanded to one year and serial
abdominal ultrasounds were substituted for the CT scans.
Five years after the initial resection, ultrasonography
revealed two 2 cm hypoechoic masses within segment IVa
of the liver adjacent to the resection margin that were sus-
picious for metastases. A contrast CT failed to demonstrate
these lesions, but both of them were clear on gadolinium-
enhanced MRI and were consistent with recurrent
hepatoma (Figure 4). At that time, his serum AFP level was
normal (1.2 ng/mL), liver function tests were normal, and
a hepatitis panel was notable for the presence of hepatitis B
core antibody and hepatitis A antibody.
Options for treatment of the lesions arising at the resec-
tion margin included repeat resection with a formal left
lobectomy and ablation with embolisation or alcohol injec-
tion. Although resection was recommended, the patient
was hesitant to proceed with an operation. Therefore,
because of the multifocal nature of his recurrence, an
angiogram was performed to assess for other lesions, and
embolisation was planned at the same time. Both lesions
were seen but there were no other tumours. The segment
IV feeding vessels were therefore embolised. On the fol-
lowing day, both lesions were injected with alcohol. The
patient tolerated both procedures without difficulty.
Discussion
The management of hepatic adenoma is challenging
because of the low but real risk of haemorrhage or malig-
nant transformation. Although malignant transformation
of pre-existing adenomata has been reported, the natural
history of these lesions is not well understood. Foster and
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Figure 2. Intraoperative evaluation revealed a large liver mass with haemor-
rhage inferiorly.
Figure 3. Hepatocellular carcinoma arising within an adenoma was seen on
(a) H & E section and (b) reticulin stain.
a
b
Figure 4. Gadolinium-enhanced MRI obtained five years after resection
revealed two foci of recurrent hepatocellular carcinoma arising at the resection
margin.
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Berman’s review of the literature found only five well-
documented reports of biopsy-proven hepatic adenoma
with malignant transformation to hepatocellular cancer [1].
In each case, a liver biopsy confirmed adenoma and the
patients were monitored. In four cases, the diagnosis of ade-
noma was made by percutaneous biopsy [1–4], while the
fifth case involved pathological examination of a left lobec-
tomy specimen, which contained multiple adenomata. This
patient developed hepatocellular cancer five years after
resection, which presumably arose from residual adenoma
in the liver remnant [5]. In addition to cases of hepatocel-
lular carcinoma arising within a known adenoma, hepato-
cellular carcinoma may also arise within a previously
undiagnosed adenoma (Table 1) [4,6–9]. Both the presence
of hepatocellular cancer arising within an adenoma and dys-
plasia occurring within an adenoma [10,11] suggest the pos-
sibility of a step-wise transformation process from adenoma
to carcinoma, although this sequence is difficult to prove.
Patients with previously undiagnosed adenoma can
present with abdominal pain due to intra-abdominal or
intratumoural haemorrhage [5,7,12]. The risk of haemor-
rhage is not known because the denominator is not well
defined. Although one large review reported that 6 of 44
patients with adenoma presented with haemorrhage [7],
Foster and Burman [1] reported no bleeding among 34
patients, 24 of whom had multiple adenoma. Thus, the true
incidence of this complication is unknown. An increased
risk of rupture is associated with the oestrogenic stimula-
tion of pregnancy or oral contraceptives [13]. There is no
definite association between size of tumour and the risk of
rupture, and although some authors suggest that larger
tumours have a greater propensity to bleed [14], massive
haemorrhage has been reported even in small lesions [13].
Adenomas are notoriously difficult to diagnose preoper-
atively by clinical, radiographical, or histological means.
The diagnostic challenge involves differentiating adenoma
from focal nodular hyperplasia or hepatocellular carci-
noma. Clinically, abdominal pain is a frequently presented
symptom [6,12], but it is not specific for adenoma versus
FNH or HCC [7,8]. Adenomas are most commonly diag-
nosed in young women taking oral contraceptives [15]; they
occur less commonly in men and are associated with the use
Table 1. Summary of all known cases of hepatocellular carcinoma arising in an adenoma
Reference Age at Number of Interval prior AFP Resected Outcome
presentation/ adenomas to malignant level
sex transformation
(years)
Hepatocellular carcinoma arising in a pre-existing adenoma
Gordon [3] 36/F solitary 3 normal yes NED 6 years after resection
Gyorffy [4] 53/F multiple 2 high no DOD 7 months after HCC
diagnosis
Foster [1] 56/F multiple 5 high no DOD 5 months after HCC
diagnosis
Leese [5] 13/M multiple 5 high transplant NED 1 year after operation
Tesluk [2] 34/F solitary 3 – yes Postoperative death
Present case 52/M solitary 11 normal yes Recurrent HCC 6 years after
operation
Hepatocellular carcinoma arising in previously undiagnosed adenoma
Ferrell [9] 29/F solitary n/a normal yes NED 4 years after operation
Weimann [7] not specified solitary n/a normal yes NED 1 year after operation
Weimann [7] not specified solitary n/a normal yes NED 1 year after operation
Belghiti [6] , 50/F solitary n/a normal yes NED 6 months after operation
Perret [15] 24/F solitary n/a normal yes NED 1 year after operation
Reddy [8] not specified/F solitary n/a normal yes NED 3 years after operation
of anabolic steroids. Adenomas can decrease in size when
oral contraceptives are discontinued [3,16].
Although radiological investigations are the most reli-
able way of differentiating adenoma from FNH or HCC,
definitive diagnosis is still not possible in many cases, even
with the use of contemporary imaging modalities. Because
these lesions can contain areas of haemorrhage, fibrosis, or
necrosis, their heterogeneous appearance can be highly
variable and may resemble hepatocellular carcinoma.
Multiphasic helical CT scanning appears to be more accu-
rate than conventional scanning in differentiating ade-
noma from other lesions [17]. However, MRI may be the
single best radiological test to differentiate adenomas, par-
ticularly with gadolinium enhancement, which shows an
early and brief blush with contrast, followed by an isoin-
tense phase [18,19]. Selected use of Tc-99 sulphur colloid
nuclear scintigraphy may facilitate differentiation from
FNH, which often show colloid uptake because they
contain Kupffer cells [20].
Despite extensive radiological evaluation with high
quality MRI or helical CT scan, it is impossible to make a
definitive diagnosis preoperatively in up to one-third of
patients with benign hepatic tumours. Because the ability
to achieve a reliable diagnosis by percutaneous biopsy is
limited due to sampling error [7,9], and because this tech-
nique may cause bleeding or needle-tract seeding [21], it is
not routinely recommended. Even when the biopsy is ade-
quate, it is difficult to distinguish reliably adenoma from
well-differentiated carcinoma or focal nodular hyperplasia
[7]. Modern cytopathological techniques such as cytopho-
tometric analysis of DNA content [22] and comparative
genomic hybridization [11] may reduce the uncertainty of
distinguishing benign lesions from well-differentiated carci-
noma, but the experience with these methods is limited.
Consequently, some patients are submitted to liver resec-
tion in order to obtain a diagnosis.
Because of the risk of haemorrhage, malignant transfor-
mation, or missed diagnosis of early malignancy, complete
surgical resection of hepatic adenoma is the treatment of
choice for all patients who can tolerate surgery. This strat-
egy is particularly important for patients symptomatic
lesions or with large, peripheral tumours, in which there is
an increased risk of haemorrhage. In addition, women who
are using fertility drugs or planning pregnancy should
undergo resection. Complete resection may require formal
lobectomy, but often these tumours are amenable to
segmental resection. The goal is complete resection with
a grossly negative margin to avoid the risk of malignancy
arising in residual adenoma.
Elevated AFP serum levels strongly suggest carcinoma
and can be diagnostic. Unfortunately, in cases of hepato-
cellular carcinoma arising within an adenoma, the AFP was
normal in over 70% of patients (Table 1), as it was in our
patient even at the time of recurrence. Thus, close follow-
up with serial imaging is essential for all patients with
hepatocellular carcinoma arising in an adenoma.
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